CoChat

The Relation between Renal Function and Serum Sclerostin in Adult Patients with CKD

Open access
Pelletier, Solenne, Dubourg, Laurence, Carlier, Marie-Christine, Hadj-Aissa, Aoumeur, Fouque, Denis · 2013 · Clinical Journal of the American Society of Nephrology
Cited by 196

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Summary: Background and objectives: Sclerostin, a bone antianabolic peptide involved in osteoporosis, is elevated in patients undergoing maintenance dialysis. However, there are no data for patients with early CKD. Design, setting, participants, & measurements: Between January and July 2010, serum sclerostin and GFR (calculated by inulin clearance) were measured in 90 patients with CKD. Fasting blood samples were also drawn for determination of calcium, phosphorus, parathyroid hormone, bone alkaline phosphatase, and 25-OH vitamin D. Results: Median GFR was 66.5 (interquartile range, 40.0–88.3) ml/min per 1.73 m 2. Median sclerostin level was 53.5 (interquartile range, 37.5–77.2) pmol/L, was higher in patients with a GFR <60 ml/min per 1.73 m 2, and was highest in those with ESRD. Sclerostin levels were significantly more elevated in men than women (P<0.05). An inverse relationship was found between sclerostin and GFR (r=−0.58; P<0.001), and a positive correlation was seen with age (r=0.34; P<0.01) and serum phosphate (r=0.26; P=0.02). In multiple regression analyses, GFR, sex, and serum phosphate were the only variables associated with serum sclerostin (P<0.001). Age lost its relationship with sclerostin level. Conclusions: This is the first study reporting higher serum sclerostin levels starting at CKD stage III. GFR, sex, and serum phosphate were the only measures associated with sclerostin level, suggesting that the effect of age reported in the literature might instead be attributable to the altered renal function in the elderly. Correcting the serum phosphorus level may be associated with lower sclerostin levels.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2215/cjn.07670712

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 196

Metadata

Authors
Pelletier, S., Dubourg, L., Carlier, M.-C., Hadj-Aissa, A., & Fouque, D.
Venue
Clinical Journal of the American Society of Nephrology
Published
2013-05
Volume
8
Issue
5
Pages
819-823
ISSN
1555-9041 (ISSN-L)
OpenAlex
W2154847297
Cited by
196
References
2
FWCI
15.69
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Relation between Renal Function and Serum Sclerostin in Adult Patients with CKD. https://app.cochat.ai/papers/10.2215/cjn.07670712
The paper
Pelletier, S., Dubourg, L., Carlier, M.-C., Hadj-Aissa, A., & Fouque, D. (2013). The Relation between Renal Function and Serum Sclerostin in Adult Patients with CKD. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.07670712

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.